Related Experiment Video
Updated: Jul 14, 2025
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
718
Insomnia and treatment-resistant depression.
Wei-Chen Lin1, John Weyl Winkelman2
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Psychiatry, School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan; Institute of Brain Science, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
Progress in Brain Research
|October 8, 2023
Summary
Depression and sleep disturbances have a strong bidirectional link. Identifying sleep issues in major depressive disorder (MDD) is crucial for treatment, especially with new objective sleep measurement tools.
Area of Science:
- Psychiatry
- Sleep Medicine
- Neuroscience
Background:
- Depression and sleep disturbances share a close, bidirectional relationship.
- Sleep disturbances, particularly insomnia, are significant risk factors for developing major depressive disorder (MDD).
- Understanding this link is vital for improving treatment outcomes in patients with treatment-resistant depression.
Purpose of the Study:
- To highlight the critical role of sleep disturbances in major depressive disorder (MDD).
- To emphasize the importance of identifying occult sleep issues in treatment-resistant depression.
- To discuss the potential of new objective sleep measurement tools in clinical practice and research.
Main Methods:
- Review of existing literature on the relationship between depression and sleep disturbances.
- Discussion of diagnostic criteria for MDD and the inclusion of sleep symptoms.
- Exploration of emerging technologies for objective sleep assessment in real-world settings.
Main Results:
- Sleep disturbance is a core symptom and risk factor in MDD, with a bidirectional influence.
- Early identification and treatment of insomnia may prevent future depressive episodes.
- Objective sleep measurement tools show promise but require further validation for widespread clinical use.
Conclusions:
- The interplay between sleep and depression is a key area for psychiatric and sleep medicine research.
- Accurate phenotyping and measurement of sleep disturbances are essential for advancing our understanding of psychiatric disorders.
- Integrating objective sleep data could revolutionize the management of depression.
Related Concept Videos
01:27Insomnia
90
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
90
01:19Management of Insomnia
266
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
266
01:23Antidepressant Drugs: MAOIs and Other Agents
260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
188
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
188
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
418
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
418
01:14CNS Depressants: Barbiturates and Benzodiazepines
293
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
293